Hims & Hers Health Inc. announced it will stop selling a copycat version of Novo Nordisk’s Wegovy weight-loss pill two days after its launch, following FDA scrutiny. Here’s all we know about the probe and US health department’s moves.
Hims & Hers halts sale of Wegovy copycat pill following FDA crackdown on weight-loss drugs
📅 Published: February 8, 2026 |
📂 Category: Uncategorized
